Investigator's Brochure (IB) Table
Drugs
| Drug Name Sort descending | Drug Company | IB Date | Risk List Available? |
|---|---|---|---|
| ABT-267, ABT 333, ABT-450 and Ritonavir | AbbVie | June 2017 | |
| Bedaquiline (TMC207) | Janssen Research & Development | February 2019 | |
| Cemiplimab (REGN2810) | Regeneron Pharmaceuticals, Inc. | May 2019 | |
| Dapivirine (Microbicide Gel) | International Partnership for Microbicides | May 2017 | |
| Dapivirine (Vaginal Ring) - New | International Partnership For Microbicides | November 2019 | |
| Delamanid (OPC-67683) | Otsuka | April 2019 | |
| Dolutegravir (GSK1349572) - New | ViiV Healthcare | November 2019 | |
| Doravirine (MK-1439) | Merck | May 2019 | |
| Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) | Merck | May 2019 | |
| Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) | Gilead Sciences | December 2016 | YES |
| Etravirine (TMC125, Intelence) - New | Janssen Research & Development | November 2019 | |
| Glecaprevir (ABT-493) and Pibrentasvir (ABT-530) | AbbVie | December 2018 | |
| GSK1265744 (Cabotegravir) | ViiV Healthcare | December 2018 | |
| HEC Placebo Gel | CONRAD | September 2011 | |
| Maraviroc (UK-427857) | ViiV Healthcare | October 2017 | |
| PC-1005 | Population Council | April 2017 | |
| Raltegravir (Isentress) | Merck | September 2017 | YES |
| Rifapentine | Sanofi | August 2013 | |
| Rilpivirine (TMC278, Edurant) | Janssen Research & Development | July 2019 | |
| Sofosbuvir/Velapatasvir (Epclusa) | Gilead | July 2016 |
Vaccines
| Vaccine Name Sort descending | Vaccine Company | IB Date | Risk List Available? |
|---|---|---|---|
| IHV01 | Profectus BioSciences Inc. | March 2019 | |
| MPER-656 Liposomes with Aluminum Hydroxide Suspension | DAIDS/NIAID/NIH | February 2019 | |
| MVA-CMDR | Walter Reed Army Institute Research (WRAIR) | February 2018 | |
| p24CE1/2 multivalent pDNA Vaccine expressing HIV M Group p24 Gag and p55 gag pDNA with IL-12 pDNA | NCI/NIAID/NIH | November 2017 | |
| PDPHV-201401 | Laboratory of Nucleic Acid Vaccines (LNAV) | October 2017 | |
| PENNVAX-GP and IL-12 DNA | Inovio Parmaceuticals | December 2016 | |
| PGDM1400 | Beth Israel Deaconess Medical Center | August 2018 | |
| PGT121 | Beth Israel Deaconess Medical Center | January 2019 | |
| PGT121.414.LS (VRC-HIVMAB0107-00-AB) - New | VCMP/NIAID/NIH | October 2019 | |
| Recombinant oligomeric gp145 C.6980 Clade C HIV Env protein | NIH/NIAID | August 2017 | |
| RSV 276 | LID/NIAID/NIH | February 2019 | |
| RSV 6120/DeltaNS2/1030s | LID/NIAID/NIH | March 2019 | |
| RSV DeltaNS2-Delta1313-I1314L | LID/NIAID/NIH | February 2019 | |
| rVSV HIV Vaccines | Profectus BioSciences | January 2016 | |
| SAR441236 | Sanofi | June 2018 | |
| VRC-HIVMAB060-00-AB (VRC01) | VRC/NIAID | August 2019 | |
| VRC-HIVMAB075-00-AB (VRC07-523LS) - New | VRC/NIAID/NIH | November 2019 | |
| VRC-HIVMAB080-00-AB (VRC01LS) | VRC/NIAID | August 2017 |